• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

ASFA Issues Updated Recommendations

August 16, 2013

The American Society for Apheresis (ASFA) has issued updated recommendations on the use of therapeutic apheresis in clinical practice. Published in the Sixth Edition of the ASFA Special Issue, these evidence-based guidelines were developed by a committee of United States-based experts from transfusion medicine/apheresis, hematology/oncology, nephrology, and other relevant fields.  The updated guidelines include 78 diseases, each of which was assigned an indication category (I-IV) describing the role of apheresis therapy and a grade of recommendation (1A-2C) based on the quality of evidence available.

Reference

1.    Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, Szczepiorkowski ZM, Williams ME, Wu Y, Shaz BH. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the american society for apheresis: the sixth special issue. J Clin Apher 2013;28: 145-284.

Filed Under

  • News
  • Policy and Guidelines

Recommended

  • T helper Cells and Alloimmunization in Patients with Sickle Cell Disease

  • Recurrence of ABO Blood Groups Stems From Trans-Species Polymorphism

  • Prothrombin Complex Concentrates are Superior to Fresh Frozen Plasma for Urgent Warfarin Reversal

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Personalized Prediction Model of Prophylactic Platelet Transfusions for Preterm Infants

  • Caffeine in Donor Blood Reduces Quality of Stored RBCs

  • Ferritin Levels Needed to Assess Hemoglobin Recovery after Blood Donation

  • Transfusion of RBCs from Cord Blood May Protect Low-Weight Preterm Infants from Severe Retinopathy

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley